43
Participants
Start Date
March 5, 2020
Primary Completion Date
January 18, 2022
Study Completion Date
May 2, 2023
Palbociclib 125mg
The Palbociclib capsules supplied for this study contains 75 mg, 100 mg or 125 mg of Palbociclib. It must be taken orally 125 mg once daily for 21 consecutive days followed by 7 days off treatment (Schedule 3/1) to comprise a complete cycle of 28 days.
Letrozole 2.5mg
Letrozole will be supplied as a 2.5 mg film-coated tablet. It must be taken at the recommended dose of 2.5 mg once daily.
UFMG - Universidade Federal de Minas Gerais, Belo Horizonte
CPO - Centro de Pesquisa em Oncologia do Hospital São Lucas da PUCRS, Porto Alegre
INCA - Instituto Nacional de Câncer, Rio de Janeiro
ICESP - Instituto do Câncer do Estado de São Paulo, São Paulo
BP - A Beneficência Portuguesa de São Paulo, São Paulo
Collaborators (1)
Pfizer
INDUSTRY
Latin American Cooperative Oncology Group
OTHER